Archive April 28, 2020 Deciphera Pharmaceuticals, Inc. to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 5, 2020
Archive March 9, 2020 Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results
Archive March 2, 2020 Deciphera Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call and Webcast on March 9, 2020
Archive February 20, 2020 Deciphera Pharmaceuticals, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Archive February 19, 2020 Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock
Archive February 13, 2020 Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Archive February 12, 2020 Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
Archive February 12, 2020 Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
Archive January 13, 2020 Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2020 Milestones
